Dopamine D2/D3 receptor agonists attenuate PTSD-like symptoms in mice exposed to single prolonged stress.

This study supports the hypothesis that the activation of dopaminergic D2/D3 receptors may be a promising pharmacotherapy for PTSD. PMID: 31085186 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31085186?dopt=Abstract

Source: Neuropharmacology - May 10, 2019 Category: Drugs & Pharmacology Authors: Malikowska-Racia N, Sałat K, Nowaczyk A, Fijałkowski Ł, Popik P Tags: Neuropharmacology Source Type: research